Can You Get Weight Loss Injections on the NHS?

Two injectable medicines are NHS-approved for weight management: tirzepatide (Mounjaro) and semaglutide (Wegovy), but NHS access follows a phased eligibility rollout that began in 2024 and is still expanding.
Current NHS tirzepatide eligibility (from June 2025) requires a BMI of 40 or above plus four or more specific weight-related conditions; a second phase lowering the BMI threshold to 35 activated in June 2026.
Semaglutide (Wegovy) is recommended by NICE but is dispensed through specialist weight management services, where waiting lists in many areas run to months or longer.
Private prescription through a regulated online pharmacy, such as a GPhC-registered service, is the legal alternative for adults who meet the licensed clinical criteria but fall outside current NHS phases or face lengthy waits.

Yes, weight loss injections are available on the NHS, but access is tightly phased and depends on strict clinical criteria. Currently, tirzepatide (Mounjaro) and semaglutide (Wegovy) are both NHS-approved medicines for weight management, yet most people asking this question today will not yet qualify under the current rollout thresholds. Here is what the criteria actually look like, and what your options are if you do not meet them or cannot wait.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How NHS access to weight loss injections actually works — phase by phase

Step 1: Which medicines the NHS has approved, and what NICE says

Two injectable GLP-1 medicines have been approved for NHS use in England for weight management. Tirzepatide, sold as Mounjaro, received a NICE recommendation in December 2024 — NICE Technology Appraisal TA1026 sets out the eligibility conditions in detail. Semaglutide (Wegovy) was recommended earlier, under NICE TA875, but only within specialist weight management services and for a maximum of two years.

NICE approval does not mean immediate open access. Both recommendations come with conditions: specific BMI thresholds, required comorbidities, and for Wegovy, a requirement to be managed within a multidisciplinary specialist service. Knowing which medicine applies to your situation is the first real question, and the answer depends on where you live and which phase of the NHS rollout is live. Scotland, Wales and Northern Ireland operate under different thresholds and commissioning arrangements, so criteria vary across the four nations, our page on NHS access in Scotland covers devolved eligibility separately.

Both medicines are prescription-only. A GP or specialist prescriber makes the final clinical decision, not the criteria alone. Meeting the thresholds on paper is necessary but not sufficient.

Step 2: The current NHS eligibility thresholds and how they are expanding

For tirzepatide on the NHS, the phased rollout in England works like this. From June 2025, the first qualifying cohort is adults with a BMI of 40 or above who also have four or more of five specific weight-related conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. That cohort became available through some GP practices from April 2026, when a new GP contract enabled primary-care prescribing, though not every practice has opted in. A second cohort (BMI 35 to 39.9 with four or more of those conditions) activated in June 2026. A further expansion to BMI 40-plus with three conditions is expected around March 2027.

For ethnic-background groups including South Asian, Chinese, Middle Eastern, Black African and African-Caribbean populations, BMI thresholds are 2.5 kg/m² lower throughout, in line with UK guidance. Our overview of who qualifies for NHS weight loss injections explains the criteria across both medicines in more depth. Even within qualifying cohorts, NHS England's guidance is clear that patients must engage with wrap-around lifestyle support, the injection does not come alone.

Wegovy follows a different route. It sits outside GP prescribing and is dispensed through specialist weight management services, where waiting times vary enormously. Some people wait well over a year. That reality is worth factoring into any plan.

Step 3: What to do if you do not qualify yet, or cannot wait

This is where most people searching this question find themselves. A private prescription, obtained through a GPhC-registered pharmacy following a full clinical consultation, is the legal route to these medicines for people outside current NHS phases. It carries no referral requirement and no waiting list, but it does require the same clinical assessment, a prescriber still reviews your health history, current medicines, BMI, and weight-related conditions before any prescription is issued. These are prescription-only medicines; that process cannot be skipped, and any seller offering them without a full clinical assessment is operating outside the law.

Private pricing varies, our page on how much weight loss injections cost sets out what typical private-market prices look like and what they should include. Getting a prescription through a properly regulated service means consultation, clinical review, a genuine supply chain, and aftercare are all part of the picture. If you are weighing up the private route, our general guide to weight loss injections is a good starting point for the broader context.

A useful practical note: GP practices that do participate in NHS prescribing under the 2026/27 contract work standard surgery hours. If that route is open to you, booking early in the week gives your GP time to review requests before Friday, something worth thinking about before the diary fills up. For those going the private route, order timing matters differently; some services dispatch the same working day if a consultation lands before noon.

Step 4: Checking your options and verifying any pharmacy you use

Whether you are exploring the NHS route or considering a private prescription, the next practical step is the same: understand your own eligibility. Our page on getting weight loss injections on prescription walks through what both routes involve. If you already know the NHS route is not yet open to you, reading about getting the injection privately explains what a regulated process looks like from start to finish.

Any online pharmacy dispensing these medicines in the UK must be registered with the GPhC. You can confirm registration at pharmacyregulation.org/registers. It takes about thirty seconds and is the single most useful check you can do before handing over any health information. The MHRA has seized large quantities of counterfeit weight-loss pens sold through unverified channels; the risk is real and the counterfeit pens have caused harm.

If you would like to understand whether a private prescription might be right for you, our prescribers at nume review every consultation personally, not through an automated system. There is no obligation, and the consultation is free. You can also browse our full weight loss treatment overview or check the FAQs for common questions before you start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions